Relationship between metabolic syndrome and proteinuria in the Japanese population

Internal Medicine

Volumn 45, Issue 9, 2006, Pages 599-603

  Miyatake, Nobuyuki ^a   Wada, Jun ^b   Kawasaki, Yuriko ^a   Matsumoto, Sumiko ^a   Makino, Hirofumi ^b   Numata, Takeyuki ^a  

^a Okayama Southern Institute of Health   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Metabolic syndrome; Prevalence; Proteinuria; Waist cirumference

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TEST STRIP; URINALYSIS; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROTEINURIA; SEX DISTRIBUTION;

EID: 33745098363     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1681     Document Type: Article

References (22)

1. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
2. Wilson PW. Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159: 1104-1109, 1999.
3. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 94: 794-809. 2005 (in Japanese).
4. Miyatake N. Kawasaki Y. Nishikawa H. Takenami S. Numata T. Prevalence of metabolic syndrome in Okayama prefecture. Japan, Intern Med 45: 107-108, 2006.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease, evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39: S1-S266, 2002.
6. Foley RN. Parfrey PS. Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112-S119, 1998.
7. Wallace JF. Pugia MJ. Lott JA. et al. Multisite evaluation of a new dipstick for albumin, protein and creatinine. J Clin Lab Anal 15: 231-235. 2001.
8. Miyatake N. Takahashi K. Wada J. et al. Changes in serum leptin concentrations in overweight Japanese men after exercise. Diabetes Obes Metab 6: 332-337. 2004.
9. The Examination Committee of Criteria for 'Obesity Disease' in Japan. Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 66: 987-992. 2002.
10. Haffner SM. Valdez RA. Hazuda HP. Mitchell BD. Morales PA. Stern MP. Prospective analysis of the insulin-resistance syndrome syndrome X). Diabetes 41: 715-722. 1992.
11. Isomaa B. Alingren P. Tuomi T. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689. 2001.
12. Lakka HM. Laaksonen DE, Lakka TA. et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716. 2002.
13. The Japanese Society of Nephrology. Available from http://www.jsn.or.jp/ (accessed 01 Nov 2005) (in Japanese).
14. Iseki K, Ikemiya Y, Fukiyama K. Predictors of end-stage renal disease and body mass index in a screened cohort. Kidney Int Suppl 63: S169-S170, 1997.
15. Kopple JD, Greene T. Chumlea WC, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int 57: 1788-1703, 2000.
16. Nelson RG. Bennett PH. Beck GJ. et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 335: 1636-1642, 1996.
17. Whelton PK, Perneger TV, He J, Klag MJ. The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence. J Hum Hypetens 10: 683-689, 1996.
18. Hunsicker LG. Adler S. Caggiula A. et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908-1919, 1997.
19. Muntner P. Coresh J. Smith JC, Eckfeldt J. Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58: 293-301. 2000.
20. Chen J. Muntner P. Hamm LL. et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174. 2004.
21. Kurella M. Lo JC. Chertow GW. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140. 2005.
22. Beddhu S. Kimmel PL, Ramkumar N, Cheung AK. Associations of metabolic syndrome with inflammation in CKD: results from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 46: 577-586. 2005.